VIROPHARMA INC: capex
| Value | {"amount": 1412000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-09-30 |
| Status | current |
| Entity | VIROPHARMA INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fa87c316-c6dd-44d3-920e-ab9ad77e8e63
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-13-079580 · Open the official SEC filing →Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000946840/capex/2013-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fa87c316-c6dd-44d3-920e-ab9ad77e8e63
History
- no predecessors — first report